Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading Companies - Gilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More

globenewswire.com
GILD Gilead Sciences is mentioned as a leading company in the stem cell and regenerative therapy market, which is projected for substantial growth. The article does not provide specific sentiment towards Gilead's performance or prospects within this market. NVS Novartis is listed as a key player in the stem cell and regenerative therapy market, a sector expected to experience significant growth. The article does not offer specific details or sentiment regarding Novartis's position or future within this market. BMY Bristol-Myers Squibb is identified as a prominent company in the stem cell and regenerative therapy market, which is forecast to grow considerably. The article does not provide specific sentiment or analysis related to Bristol-Myers Squibb's role or performance. ORGN Organogenesis is mentioned as a leading company within the stem cell and regenerative therapy market, a sector projected for substantial growth. The article does not provide specific sentiment or details about Organogenesis's performance or outlook.

Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Stem Cell and Regenerative Therapy: Global Markets" has been added to ResearchAndMarkets.com's offering.

The global stem cell and regenerative therapy market is poised for substantial growth, with projections indicating an increase from $16.7 billion in 2025 to $43.8 billion by 2030, reflecting a compound annual growth rate (CAGR) of 21.3%. This burgeoning sector is driven by its potential to address chronic and challenging health conditions, including cancer, Parkinson's, Alzheimer's, diabetes, and cardiovascular diseases.

Investments from private companies and governments worldwide are catalyzing progress in stem cell research, aiming to meet increasing demands for innovative treatment and prevention solutions for chronic diseases. Technological advancements are focusing on optimizing stem cell culture technology, contributing to reduced treatment costs and facilitating research advancements. Notable progress has been made in refining stem cell culture media formulations, culture systems, and the equipment used for stem cell development and processing.

Report Scope

The report offers a comprehensive analysis of the global stem cell and regenerative therapy market, covering market trends, revenue forecasts, and segmentation by products, services, application, and geographical regions, including North America, Europe, Asia-Pacific, and the Rest of the World. It delves into significant trends and challenges impacting the market and vendor landscape, with insights into environmental, social, and corporate governance (ESG) developments, emerging technologies, and the patent landscape.

Concluding with an examination of the competitive landscape, the report provides ranking and shares of major companies within the global stem cell and regenerative medicine market. It features company profiles offering overviews, financial details, product portfolios, and recent developments of key market players.

The report includes:

Key Attributes

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/jc4ijq

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment